Definitive Healthcare Corp. Class A Common Stock Q2 2025 Earnings Recap

DH Q2 2025 August 8, 2025

Get alerts when DH reports next quarter

Definitive Healthcare reported Q2 2025 results that exceeded expectations, reflecting improved renewal rates and strong operational efficiencies despite a year-over-year revenue decline.

Earnings Per Share Beat

$0.07 vs $0.05 est.

+40.0% surprise

Revenue Beat

60750000 vs 59236500 est.

+2.6% surprise

Market Reaction

1-Day -2.77%

5-Day -9.45%

30-Day +1.51%

See DH alongside your other holdings

Add to your portfolio — free

Key Takeaways

Total revenue was $60.8 million, down 5% year-over-year but above guidance; early signs of improved renewal rates were noted.
Adjusted EBITDA reached $18.7 million, representing a 31% margin, supported by disciplined expense management and scalable operations.
New logo activity remained robust, indicating strong customer demand for the company's differentiated healthcare data solutions.
Highest retention rate since Q2 of last year reinforces positive momentum, despite upcoming larger renewal periods in December and January.
Guidance for revenue and adjusted EBITDA has been increased, reflecting confidence from first-half performance.

This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit DH on AllInvestView.

Next Q3 2025